Talking Points
ਚੈਨਲ ਵਿਸਥਾਰ
Talking Points
A selection of the best interviews conducted by physician leaders and recorded at cardiology conferences around the globe. 06f763f0-76e5-11f0-bb7c-8557ae1d8a8b
ਹਾਲੀਆ ਐਪੀਸੋਡ
192 ਐਪੀਸੋਡ
The ECLIPSE Trial
Ajay Kirtane and C. Michael Gibson discuss how orbital atherectomy compares with balloon angioplasty for severely calcified coronary arteries before D...
The CLEAR SYNERGY (OASIS 9) Trial
Does long-term colchicine benefit patients after acute MI? C. Michael Gibson and Sanjit Jolly discuss.
The NOTION-3 Trial
Mamas Mamas talks to Jacob Thomsen Lønborg about how PCI affects outcomes for patients with stable CAD undergoing TAVI.
TMVR in the Heart Failure Paradigm
Transcatheter devices are new to the heart failure (HF) community and treatment armamentarium for severe MR. This discussion focuses on the impact of...
The ABYSS Trial
Johanne Silvain, Gilles Montalescot, and C. Michael Gibson discuss the effects of beta-blocker interruption in post-MI patients.
Patient Selection and Treatment Goals
Patient selection is important for transcatheter interventions and impacts result success. This discussion focuses on defining what treatment goals sh...
Women's Health Study: Biomarkers
Paul Ridker and C. Michael Gibson discuss 30-year data hinting at how three modifiable factors—LDL, hs-CRP, and Lp(a)—might be leveraged to reduce lon...
Echocardiography and Quality Data
Clinical trials face challenges with variability in echo images, protocol adherence, and data quality. This discussion focuses on strategies to improv...
Insights on Intrepid 2-Yr Mitral TF EFS
The Intrepid TMVR system just released 2-year transfemoral EFS outcomes at NY Valves. This discussion provides a deeper dive into what this data means...
New ESC Guidelines for AF
Renate Schnabel, Ruben Casado Arroyo, and Mamas Mamas discuss the atrial fibrillation recommendations unveiled at ESC Congress 2024.
The STEEER-AF Trial
Dipak Kotecha talks to C. Michael Gibson about whether educating healthcare providers on rhythm-control therapy affects guideline adherence and stroke...
The EPIC-CAD Trial
Gi-Byoung Nam, Duk-Woo Park, and C. Michael Gibson weigh edoxaban monotherapy vs dual antithrombotic therapy for patients with AF and stable coronary...
Acute Coronary Care in Ethiopia
Mamas Mamas talks to Tesfaye Telila about the landscape of acute coronary care in Ethiopa, where just a few dozen cardiologists contend with a populat...
The POPular PAUSE TAVI Trial
Should we stop anticoagulation therapy before TAVI in patients with aortic stenosis? Dirk-Jan van Ginkel and C. Michael Gibson discuss.
The SENIOR-RITA Trial
Vijay Kunadian talks to C. Michael Gibson about using an invasive or conservative strategy for older patients with NSTEMI.
The REDUCE-AMI Trial
Troels Yndigegn, Sripal Bangalore, and Mamas Mamas discuss whether beta-blockers still benefit patients with acute MI and preserved ejection fraction.
The EARTH-STEMI Trial
Gianluca Campo and C. Michael Gibson compare complete versus culprit-only revascularization in older STEMI patients.
The SCOFF Trial
David Ferreira talks to C. Michael Gibson about the latest data showing patients don't need to fast ahead of cardiac catheterization.
The RESHAPE-HF2 and MATTERHORN Trials
Mamas Mamas, Stefan Anker, and Volker Rudolph talk about their studies of MitraClip for functional MR in patients with heart failure.
The EMPACT-MI Trial
Javed Butler and C. Michael Gibson discuss the trial testing early empagliflozin after acute MI.
The PROACT Trial
Talking with C. Michael Gibson, David Austin reviews the phase III trial of enalapril for anthracycline-induced cardiotoxicity in lymphoma and breast...
The ORBITA-COSMIC Trial
Rasha Al-Lamee and Michael Foley sit down with Mamas Mamas to discuss data on an implantable coronary sinus reducer that can ease symptoms in patients...
The REVIVED-BCIS2 Randomized Trial
Looking at the REVIVED-BCIS2 results, Divaka Perera and C. Michael Gibson discuss the relationship between myocardial viability, PCI, and outcomes.
Ketogenic Diet and Cardiovascular Risk
Iulia Iatan talks to C. Michael Gibson about how a low-carbohydrate, high-protein diet can increase plasma lipid levels and cardiovascular risk.
The CLEAR Outcomes Trial
Steven Nissen and C. Michael Gibson discuss using bempedoic acid to reduce MACE in statin-intolerant patients with high cardiovascular risk.
Inflammatory Risk in Statin-Treated Patients
Pooling data from the PROMINENT, REDUCE-IT, and STRENGTH trials, Paul Ridker and C. Michael Gibson discuss the residual inflammatory risks for patient...
The BUDAPEST CRT Upgrade Trial
Béla Merkely and C. Michael Gibson discuss the results of a CRT-D upgrade versus ICD alone for HFrEF patients with right ventricular pacing.
The HEART-FID Trial
Robert Mentz and C. Michael Gibson discuss the latest trial to address whether iron supplementation, this time with ferric carboxymaltose, improves ou...
The FIRE Study
Simone Biscaglia and C. Michael Gibson discuss physiology-guided complete revascularization versus culprit-only PCI for elderly patients with acute MI...
The ECLS-SHOCK Trial
Holger Thiele and C. Michael Gibson discuss the impact of VA-ECMO on patients with acute MI and advanced cardiogenic shock.
The STOPDAPT-3 Trial
Masahiro Natsuaki and C. Michael Gibson discuss this latest randomized comparison of prasugrel monotherapy and DAPT with aspirin for patients undergoi...
The ILUMIEN IV Trial
Ziad Ali and C. Michael Gibson take a deeper dive into this comparison of OCT- and angiography-guided PCI.
OCT vs IVUS vs Angiography: A Meta-analysis
Gregg Stone and C. Michael Gibson discuss an updated meta-analysis addressing intravascular imaging in DES implantation.
The ATTRibute-CM Trial
Julian Gillmore and C. Michael Gibson discuss the efficacy of acoramidis for patients with transthyretin amyloid cardiomyopathy.
The ADVENT Trial
Vivek Reddy and C. Michael Gibson compare pulsed field ablation versus thermal ablation for patients with paroxysmal atrial fibrillation.
The ARAMIS Trial
Mathieu Kerneis and C. Michael Gibson compare outcomes of patients treated with anakinra, a new therapy for acute myocarditis, or placebo.
The NITRATE-CIN Trial
Dan Jones and C. Michael Gibson discuss whether inorganic nitrate reduces contrast-induced nephropathy after angiography in ACS patients.
The DICTATE-AHF Trial
Zachary Cox and C. Michael Gibson discuss whether early dapagliflozin initiation is safe and effective for patients with acute heart failure.
The RIGHT Trial
Shaoping Nie, Gilles Montalescot, and C. Michael Gibson discuss prolonged anticoagulation after primary PCI for patients with MI.
Four-Year Results: The EVOLUT Low Risk Trial
Michael J. Reardon and C. Michael Gibson discuss the trial's 4-year results in low-surgical-risk patients with severe aortic stenosis randomized to se...